citalopram has been researched along with buprenorphine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackermann, G; Waizmann, M | 1 |
| Anderson, BJ; Cioe, PA; Friedmann, PD; Herman, DS; Kettavong, M; Stein, MD; Tellioglu, T | 1 |
| Anderson, BJ; Brown, RA; Herman, DS; Sims, M; Stein, MD; Strong, DR | 1 |
| Cunningham, JI; Dean, RL; Deaver, DR; Eyerman, DJ; Sanchez, C; Smith, KL | 1 |
2 trial(s) available for citalopram and buprenorphine
| Article | Year |
|---|---|
Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons.
Topics: Adult; Antidepressive Agents; Buprenorphine; Citalopram; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders | 2010 |
Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.
Topics: Adult; Antidepressive Agents, Second-Generation; Buprenorphine; Citalopram; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Middle Aged; Motivation; Narcotics; Opioid-Related Disorders; Patient Dropouts; Probability; Risk Assessment; Stress, Psychological; Substance Abuse Detection; Substance Withdrawal Syndrome | 2012 |
2 other study(ies) available for citalopram and buprenorphine
| Article | Year |
|---|---|
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Buprenorphine; Citalopram; Depression; Directly Observed Therapy; Drug Administration Schedule; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2010 |
Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Buprenorphine; Citalopram; Depressive Disorder, Major; Dopamine; Drug Combinations; Drug Therapy, Combination; Male; Models, Animal; Motor Activity; Naltrexone; Rats; Rats, Inbred WKY; Serotonin; Swimming | 2019 |